News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

08/11/2020

Atriva announces closing of € 8.6 million ($ 10.2 million) oversubscribed convertible loan

Round led by existing investors Meneldor and High-Tech Gründerfonds Proceeds to be used to start Phase II study with ATR-002 in moderate to severe COVID-19 and clinical development in influenza and other respiratory viral infections ATR-002 mode of action inhibits viral propagation of respiratory RNA viruses and prevents the cytokine storm, ...
08/10/2020 | CureVac AG

CureVac Announces Proposed Initial Public Offering of Common Shares

TÜBINGEN, Germany/ BOSTON, USA – August 10, 2020 – CureVac B.V. (“CureVac” or the “Company”), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announced today that it intends to offer and sell in an underwritten public offering of 13,333,333 common share...
08/06/2020 | immatics biotechnologies GmbH

Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth

Extension of collaboration between UTHealth and Immatics until end of 2024 providing Immatics exclusive access to state-of-the art cGMP manufacturing infrastructure at The Evelyn H. Griffin Stem Cell Therapeutics Research Laboratory Collaboration ensures continued clinical batch supply for all of Immatics’ ongoing and next Adoptive Cell Therap...
08/04/2020 | CureVac AG

CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer

TÜBINGEN, Germany/ BOSTON, USA – August 4, 2020 – CureVac today announced that Dr. Franz-Werner Haas, previously acting Chief Executive Officer and Chief Operating Officer (COO), has been appointed Chief Executive Officer (CEO).
07/31/2020 | Festo AG & Co. KG

Festo App wins at the Give a Breath Challenge

Munich Re and Fraunhofer honour ideas for the treatment of Covid-19   On July 29th, Festo and the Fraunhofer IPA were honoured for their developed App "Virus Fighters Handbook" at the Award Ceremony of the Give a Breath Challenge in Munich, an ideas competition organised by Munich Re and the Fraunhofer Society to combat the corona crisis. ...
07/31/2020 | Insilico Biotechnology AG

Insilico Biotechnology AG reports progress on the use of methanol for the sustainable production of fine chemicals

As a partner in the Chiramet research consortium Insilico Biotechnology has identified methods to increase the productivity of biological cells to manufacture chiral building blocks from methanol.
07/28/2020 | Ovesco Endoscopy AG

Webinar: Resection techniques in endoluminal surgery – now available online

Expand your horizon on resection techniques in endoluminal surgery.
07/21/2020 | Ovesco Endoscopy AG

stentfix OTSC® System: case series shows the new stentfix device to prevent effectively esophageal stent migration

stentfix OTSC was used in five complex cases who already had experienced stent migration and were considered unfit for surgery. Placement of stentfix OTSC resulted in immediate technical success in all patients. Stent migration or fixation-related adverse events did not occur in any patient.
07/21/2020 | CureVac AG

CureVac Raises a Total of USD 640 Million in Private Financing Round

Financing Round includes previously announced investments from German Federal Government and GSK for an amount of USD 514 Million   Additional USD 126 million raised, including participation of Qatar Investment Authority (QIA)    
07/20/2020 | CureVac AG

GSK and CureVac announce strategic mRNA technology collaboration

Companies to collaborate on mRNA vaccine and monoclonal antibody research programmes in infectious diseases   GSK to make equity investment of £130m (€150m) in CureVac, and an upfront payment of £104m (€120m)    
[DE Copy] The screen is divided into the speaker view and a shared content for the KIKS project.
07/10/2020 | BioLAGO e.V. - das Gesundheitsnetzwerk

Patients in focus: International Forum for Artificial Intelligence in Medicine

On 6 July 2020, around 100 medical technology experts from Germany, Ireland and Switzerland came together at the invitation of the BioLAGO e.V. health network and Medical Mountains GmbH, to discuss how artificial intelligence (AI) can be utilized to further improve the performance and safety of medical products.
07/09/2020 | immatics biotechnologies GmbH

Immatics Announces Board of Directors Additions Following Public Listing on NASDAQ

Houston, Texas and Tuebingen, Germany, July 9, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, today announced changes to its Board of Directors in conjunction with its recent listing on NASDAQ. Michael Atieh, Paul ...
07/08/2020 | Ovesco Endoscopy AG

OTSC® management of non-acute full-thickness gastrointestinal defects represents an effective and safe alternative to a potentially morbid surgical intervention

92 patients with 117 non-acute full-thickness gastrointestinal defects (65 fistulas, 52 leaks) underwent OTSC therapy. With a median follow-up time of 5.5 months, overall defect closure success rate was 66.1 %. Only 14.9 % of patients underwent opera...
07/08/2020 | Eberhard Karls Universität Tübingen

New ways to keep proteins healthy outside the cell

University of Tübingen researchers identify extracellular protein quality regulators with implications for Alzheimer's and other neurodegenerative diseases
07/06/2020 | CureVac AG

Germany: EIB and European Commission provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing

European Investment Bank and CureVac sign €75 million loan agreement for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against SARS-CoV-2 The EIB loan will support CureVac’s activities to complete its new messenger ribonucleic acid (mRNA) production facility in Tübingen, Germany The transaction...
Ein Mann und eine Frau stehen vor einer Maschine in einem Labor.
07/03/2020 | NMI Naturwissenschaftliches und Medizinisches Institut

Representative, nationwide corona antibody study starts in Reutlingen

NMI in Reutlingen supports study with reliable detection method
07/02/2020 | immatics biotechnologies GmbH

Immatics Announces Completion of Business Combination and Listing on NASDAQ

The business combination transaction with Arya Sciences Acquisition Corporation, a special purpose acquisition company sponsored by Perceptive Advisors, was completed on July 1, 2020 The combined company was renamed Immatics N.V. Immatics common stock and warrants will commence trading today on the Nasdaq Capital Markets under the ticker sym...
07/01/2020 | Insilico Biotechnology AG

Future-proof data handling: Insilico releases the Insilico Data Cleaner, a solution for advanced model-based data curation

(Stuttgart) Insilico Biotechnology AG launches new data connectivity solution for coping with increased demand for predictive solutions in biologics manufacturing and process development.
06/30/2020 | Atriva Therapeutics GmbH

Publication in PNAS unveils molecular pathway required for influenza virus replication with large potential as an antiviral drug target

For the first time, research explains the cascade of events linking influenza virus-induced activation of the Raf/MEK/ERK pathway to the nuclear export of viral ribonucleoprotein (vRNP) via the host protein RSK   Raf/MEK/ERK/RSK pathway represents an Achilles heel of virus replication and is a target of the ongoing antiviral development by...
06/29/2020 | immatics biotechnologies GmbH

Arya Sciences Acquisition Corp. Shareholders Approve Business Combination Transaction with Immatics

New York, NY, Houston, TX and Tuebingen, Germany, June 29, 2020 – Arya Sciences Acquisition Corp. (NASDAQ: ARYA or “Arya”), a special purpose acquisition company sponsored by Perceptive Advisors, and Immatics Biotechnologies GmbH (“Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting c...